This inventor holds 5 USPTO granted patents. Top assignee: University of Iowa Research Foundation. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: Wallace L M Alward: Innovator in Glaucoma Therapeutics
Introduction
Wallace L M Alward is a prominent inventor based in Iowa City, IA, known for his significant contributions to the field of glaucoma therapeutics and diagnostics. With a total of five patents to his name, Alward has made strides in developing methods and compositions aimed at preventing and treating glaucoma.
Latest Patents
Among his latest patents, Alward has focused on innovative approaches to glaucoma. One of his notable patents involves methods and compositions for preventing and treating glaucoma, as well as diagnostics related to the condition. Additionally, he has developed methods to identify modulators of FKHL7 DNA-binding activity, which are crucial for treating congenital heart disease and for prognosing or diagnosing this condition in subjects.
Career Highlights
Alward is affiliated with the University of Iowa Research Foundation, where he continues to advance research in his field. His work has garnered attention for its potential impact on improving patient outcomes in glaucoma and congenital heart disease.
Collaborations
Throughout his career, Alward has collaborated with esteemed colleagues, including Edwin M Stone and Val C Sheffield, further enhancing the scope and depth of his research.
Conclusion
Wallace L M Alward's innovative work in glaucoma therapeutics and diagnostics exemplifies his commitment to advancing medical science. His contributions are vital in addressing significant health challenges, particularly in the areas of eye health and congenital heart disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile